HomeCNTX • NASDAQ
add
Context Therapeutics Inc
Previous close
$1.46
Day range
$1.42 - $1.53
Year range
$0.77 - $2.73
Market cap
104.96M USD
Avg Volume
301.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.70M | 202.59% |
Net income | -17.46M | -197.21% |
Net profit margin | — | — |
Earnings per share | -0.22 | 40.54% |
EBITDA | -18.70M | -202.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 84.80M | 291.21% |
Total assets | 86.33M | 275.53% |
Total liabilities | 2.47M | -46.30% |
Total equity | 83.86M | — |
Shares outstanding | 75.00M | — |
Price to book | 1.30 | — |
Return on assets | -49.46% | — |
Return on capital | -50.49% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -17.46M | -197.21% |
Cash from operations | -1.93M | 44.14% |
Cash from investing | -14.76M | — |
Cash from financing | -44.63K | — |
Net change in cash | -16.74M | -383.55% |
Free cash flow | -25.71M | -1,646.21% |
About
Founded
2015
Headquarters
Website
Employees
5
